✦ LIBER ✦

Retreatment with high vs. conventional doses of consensus interferon and ribavirin of patients with non-response or relapse after previous treatment with alpha-interferon

✍ Scribed by W.O. Bocher; P.R. Galle; H.F. Löhr

Book ID: 117372587
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 164 KB
Volume: 38
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)80700-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1012 Consensus interferon and ribavirin

1012 Consensus interferon and ribavirin retreatment of chronic HCV patients with non-response or relapse after previous alpha-interferon therapy

✍ BOECHER, W; SPRINZL, M; MUDTER, J; HILLENBRAND, H; BROCKMANN, H; GALLE, P; LOEHR 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

13 P Interferon alpha plus ribavirin and

13 P Interferon alpha plus ribavirin and amantadine in chronic hepatitis C patients with previous non response or relapse to interferon and ribavirin

✍ A.Galeota Lanza; T. Ascione; W. Utech; G. Leone; A. Ascione 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Increased sustained response of HCV rela

Increased sustained response of HCV relapsing patients with consensus interferon (ALFACON) vs recombinant alpha-interferon-2b plus ribavirin (IFN+RB)

✍ L. Miglioresi; F. Russo; F. Patrizi; S. D'Innocenzo; M. Bacosi; G.L. Ricci 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 138 KB

248 Retreatment of standard interferon/r

248 Retreatment of standard interferon/ribavirin nonresponder patients with chronic hepatitis C with daily consensus interferon and ribavirin yields high sustained response rates

✍ Stephan Kaiser; Holger G. Hass; Michael Gregor 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of

High viral response rates in previous no

High viral response rates in previous nonresponder patients with hepatitis C treated with daily dosing of consensus interferon and ribavirin

✍ Stephan Kaiser; Christian Kreysel; Holger Hass; Michael Gregor 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB